CHRETO ApS: Financial statements 2014
CVR: 33382170
Source: annual report 2014, Danish Business Authority
01/07/2013 – 30/06/2014
CHRETO ApS (CVR 33382170) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 4,711 and a net result of DKK 4,711 compared with DKK 13,142 the year before. That is a decrease of 63.9% compared with the year before. Equity in the 2014 report amounted to DKK 167,143. The solvency ratio was 9.9%.
- Gross Profit
- DKK 4,711
- Profit/Loss
- DKK 4,711
- Equity
- DKK 167,143
- Total Assets
- DKK 1,686,269
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 5 t. | 5 t. | 167 t. | - |
| 2013 | - | 13 t. | 13 t. | 162 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of September 13, 2014, Torben Vedel Stahl Jørgensen has joined the board of directors of CHRETO ApS.
As of September 13, 2014, Geert W Nygaard has joined the board of directors of CHRETO ApS.
As of September 13, 2014, Geert W Nygaard has left the board of directors of CHRETO ApS.
About CHRETO ApS
CHRETO ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jan Kyhse-Andersen. The board consists of Johan Caspar Foghsgaard (chair), Anders Wikström, Frank Bech Nygaard and Kim Bjørnstrup. The company's owners include NOVOZYMES A/S, SKEIKAMPEN INVEST ApS and JAN KYHSE-ANDERSEN HOLDING ApS. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK -2,662,874 and a net result of DKK -3,119,901 compared with DKK -2,336,562 the year before. Equity in the 2025 report amounted to DKK 49,010,862.